Molecular	O
cloning	O
and	O
biochemical	O
characterization	O
of	O
a	O
truncated	O
,	O
secreted	B
member	O
of	O
the	O
human	O
family	O
of	O
Ca2	O
+	O
-activated	O
Cl-	O
channels	O
.	O

A	O
novel	O
family	O
of	O
chloride	O
channel	O
proteins	O
has	O
recently	O
been	O
discovered	O
including	O
two	O
bovine	O
(	O
Lu	B
-	I
ECAM-1	I
,	O
bCLCA1	B
)	O
,	O
one	O
murine	O
(	O
mCLCA1	B
)	O
,	O
and	O
two	O
human	O
(	O
hCLCA1	B
and	O
hCLCA2	B
)	O
members	O
.	O

Here	O
,	O
we	O
describe	O
the	O
cloning	O
,	O
expression	O
,	O
and	O
molecular	O
characterization	O
of	O
a	O
truncated	O
human	O
homolog	O
,	O
tentatively	O
named	O
hCLCA3	B
.	O

It	O
was	O
cloned	O
from	O
a	O
human	O
spleen	O
cDNA	O
library	O
and	O
is	O
expressed	O
in	O
numerous	O
tissues	O
including	O
lung	O
,	O
trachea	O
,	O
spleen	O
,	O
thymus	O
,	O
and	O
mammary	O
gland	O
as	O
determined	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
.	O

Unlike	O
all	O
previously	O
known	O
CLCA	O
family	O
members	O
which	O
consistently	O
encode	O
an	O
approximately	O
125-kDa	O
transmembrane	B
protein	O
that	O
is	O
cleaved	O
to	O
form	O
a	O
heterodimer	O
of	O
two	O
proteins	O
of	O
approximately	O
90	O
and	O
35	O
kDa	O
,	O
the	O
3.6-kb	O
hCLCA3	B
mRNA	O
encodes	O
a	O
37-kDa	O
glycoprotein	O
that	O
corresponds	O
to	O
the	O
N	O
-	O
terminal	O
extracellular	B
domain	O
of	O
its	O
homologs	O
.	O

Moreover	O
,	O
when	O
expressed	O
in	O
human	O
embryonic	O
kidney	O
293	O
or	O
Chinese	O
hamster	O
ovary	O
cells	O
,	O
this	O
37-kDa	O
glycoprotein	O
is	O
secreted	B
into	O
the	O
culture	O
supernatant	O
.	O

These	O
observations	O
suggest	O
that	O
hCLCA3	B
is	O
a	O
structurally	O
divergent	O
member	O
of	O
the	O
CLCA	O
family	O
of	O
proteins	O
and	O
that	O
it	O
does	O
not	O
act	O
as	O
a	O
channel	O
protein	O
but	O
has	O
distinct	O
,	O
yet	O
unidentified	O
functions	O
.	O

Yeast	O
mutants	O
affecting	O
possible	O
quality	O
control	O
of	O
plasma	B
membrane	I
proteins	O
.	O

Mutations	O
gef1	B
,	O
stp22	B
,	O
STP26	B
,	O
and	O
STP27	B
in	O
Saccharomyces	O
cerevisiae	O
were	O
identified	O
as	O
suppressors	O
of	O
the	O
temperature	O
-	O
sensitive	O
alpha	O
-	O
factor	O
receptor	O
(	O
mutation	O
ste2	B
-	I
3	I
)	O
and	O
arginine	B
permease	I
(	O
mutation	O
can1	B
(	O
ts	O
)	O
)	O
.	O

These	O
suppressors	O
inhibited	O
the	O
elimination	O
of	O
misfolded	O
receptors	O
(	O
synthesized	O
at	O
34	O
degrees	O
C	O
)	O
as	O
well	O
as	O
damaged	O
surface	O
receptors	O
(	O
shifted	O
from	O
22	O
to	O
34	O
degrees	O
C	O
)	O
.	O

The	O
stp22	B
mutation	O
(	O
allelic	O
to	O
vps23	B
[	O
M.	O
Babst	O
and	O
S.	O
Emr	O
,	O
personal	O
communication	O
]	O
and	O
the	O
STP26	B
mutation	O
also	O
caused	O
missorting	O
of	O
carboxypeptidase	B
Y	I
,	O
and	O
ste2	B
-	I
3	I
was	O
suppressed	O
by	O
mutations	O
vps1	B
,	O
vps8	B
,	O
vps10	B
,	O
and	O
vps28	B
but	O
not	O
by	O
mutation	O
vps3	B
.	O

In	O
the	O
stp22	B
mutant	O
,	O
both	O
the	O
mutant	O
and	O
the	O
wild	O
-	O
type	O
receptors	O
(	O
tagged	O
with	O
green	B
fluorescent	I
protein	I
[	O
GFP	B
]	O
)	O
accumulated	O
within	O
an	O
endosome	B
-	O
like	O
compartment	O
and	O
were	O
excluded	O
from	O
the	O
vacuole	B
.	O

GFP	B
-	O
tagged	O
Stp22p	B
also	O
accumulated	O
in	O
this	O
compartment	O
.	O

Upon	O
reaching	O
the	O
vacuole	B
,	O
cytoplasmic	B
domains	O
of	O
both	O
mutant	O
and	O
wild	O
-	O
type	O
receptors	O
appeared	O
within	O
the	O
vacuolar	B
lumen	O
.	O

Stp22p	B
and	O
Gef1p	B
are	O
similar	O
to	O
tumor	O
susceptibility	O
protein	O
TSG101	B
and	O
voltage	O
-	O
gated	O
chloride	O
channel	O
,	O
respectively	O
.	O

These	O
results	O
identify	O
potential	O
elements	O
of	O
plasma	B
membrane	I
quality	O
control	O
and	O
indicate	O
that	O
cytoplasmic	B
domains	O
of	O
membrane	B
proteins	O
are	O
translocated	O
into	O
the	O
vacuolar	B
lumen	O
.	O

Apg13p	B
and	O
Vac8p	B
are	O
part	O
of	O
a	O
complex	O
of	O
phosphoproteins	O
that	O
are	O
required	O
for	O
cytoplasm	B
to	O
vacuole	B
targeting	O
.	O

We	O
have	O
been	O
studying	O
protein	O
components	O
that	O
function	O
in	O
the	O
cytoplasm	B
to	O
vacuole	B
targeting	O
(	O
Cvt	B
)	O
pathway	O
and	O
the	O
overlapping	O
process	O
of	O
macroautophagy	O
.	O

The	O
Vac8	B
and	O
Apg13	B
proteins	O
are	O
required	O
for	O
the	O
import	O
of	O
aminopeptidase	O
I	O
(	O
API	O
)	O
through	O
the	O
Cvt	B
pathway	O
.	O

We	O
have	O
identified	O
a	O
protein	O
-	O
protein	O
interaction	O
between	O
Vac8p	B
and	O
Apg13p	B
by	O
both	O
two	O
-	O
hybrid	O
and	O
co	O
-	O
immunoprecipitation	O
analysis	O
.	O

Subcellular	O
fractionation	O
of	O
API	O
indicates	O
that	O
Vac8p	B
and	O
Apg13p	B
are	O
involved	O
in	O
the	O
vesicle	O
formation	O
step	O
of	O
the	O
Cvt	B
pathway	O
.	O

Kinetic	O
analysis	O
of	O
the	O
Cvt	B
pathway	O
and	O
autophagy	O
indicates	O
that	O
,	O
although	O
Vac8p	B
is	O
essential	O
for	O
Cvt	B
transport	O
,	O
it	O
is	O
less	O
important	O
for	O
autophagy	O
.	O

In	O
vivo	O
phosphorylation	O
experiments	O
demonstrate	O
that	O
both	O
Vac8p	B
and	O
Apg13p	B
are	O
phosphorylated	O
proteins	O
,	O
and	O
Apg13p	B
phosphorylation	O
is	O
regulated	O
by	O
changing	O
nutrient	O
conditions	O
.	O

Although	O
Apg13p	B
interacts	O
with	O
the	O
serine	O
/	O
threonine	O
kinase	O
Apg1p	B
,	O
this	O
protein	O
is	O
not	O
required	O
for	O
phosphorylation	O
of	O
either	O
Vac8p	B
or	O
Apg13p	B
.	O

Subcellular	O
fractionation	O
experiments	O
indicate	O
that	O
Apg13p	B
and	O
a	O
fraction	O
of	O
Apg1p	B
are	O
membrane	B
-	O
associated	O
.	O

Vac8p	B
and	O
Apg13p	B
may	O
be	O
part	O
of	O
a	O
larger	O
protein	O
complex	O
that	O
includes	O
Apg1p	B
and	O
additional	O
interacting	O
proteins	O
.	O

Together	O
,	O
these	O
components	O
may	O
form	O
a	O
protein	O
complex	O
that	O
regulates	O
the	O
conversion	O
between	O
Cvt	B
transport	O
and	O
autophagy	O
in	O
response	O
to	O
changing	O
nutrient	O
conditions	O
.	O

Mdv1p	B
is	O
a	O
WD	O
repeat	O
protein	O
that	O
interacts	O
with	O
the	O
dynamin	O
-	O
related	O
GTPase	O
,	O
Dnm1p	B
,	O
to	O
trigger	O
mitochondrial	B
division	O
.	O

Mitochondrial	B
fission	O
is	O
mediated	O
by	O
the	O
dynamin	O
-	O
related	O
GTPase	O
,	O
Dnm1p	B
,	O
which	O
assembles	O
on	O
the	O
mitochondrial	B
outer	I
membrane	I
into	O
punctate	O
structures	O
associated	O
with	O
sites	O
of	O
membrane	B
constriction	O
and	O
fission	O
.	O

We	O
have	O
identified	O
additional	O
nuclear	B
genes	O
required	O
for	O
mitochondrial	B
fission	O
,	O
termed	O
MDV	O
(	O
for	O
mitochondrial	B
division	O
)	O
.	O

MDV1	B
encodes	O
a	O
predicted	O
soluble	O
protein	O
,	O
containing	O
a	O
coiled	O
-	O
coil	O
motif	O
and	O
seven	O
COOH	O
-	O
terminal	O
WD	O
repeats	O
.	O

Genetic	O
and	O
two	O
-	O
hybrid	O
analyses	O
indicate	O
that	O
Mdv1p	B
interacts	O
with	O
Dnm1p	B
to	O
mediate	O
mitochondrial	B
fission	O
.	O

In	O
addition	O
,	O
Mdv1p	B
colocalizes	O
with	O
Dnm1p	B
in	O
fission	O
-	O
mediating	O
punctate	O
structures	O
on	O
the	O
mitochondrial	B
outer	I
membrane	I
.	O

Whereas	O
localization	O
of	O
Mdv1p	B
to	O
these	O
structures	O
requires	O
Dnm1p	B
,	O
localization	O
of	O
Mdv1p	B
to	O
mitochondrial	B
membranes	I
does	O
not	O
.	O

This	O
indicates	O
that	O
Mdv1p	B
possesses	O
a	O
Dnm1p	B
-	O
independent	O
mitochondrial	B
targeting	O
signal	O
.	O

Dnm1p	B
-	O
independent	O
targeting	O
of	O
Mdv1p	B
to	O
mitochondria	B
requires	O
MDV2	B
.	O

Our	O
data	O
indicate	O
that	O
MDV2	B
also	O
functions	O
separately	O
to	O
regulate	O
the	O
assembly	O
of	O
Dnm1p	B
into	O
punctate	O
structures	O
.	O

In	O
contrast	O
,	O
Mdv1p	B
is	O
not	O
required	O
for	O
the	O
assembly	O
of	O
Dnm1p	B
,	O
but	O
Dnm1p	B
-	O
containing	O
punctate	O
structures	O
lacking	O
Mdv1p	B
are	O
not	O
able	O
to	O
complete	O
division	O
.	O

Our	O
studies	O
suggest	O
that	O
mitochondrial	B
fission	O
is	O
a	O
multi	O
-	O
step	O
process	O
in	O
which	O
Mdv2p	B
regulates	O
the	O
assembly	O
of	O
Dnm1p	B
into	O
punctate	O
structures	O
and	O
together	O
with	O
Mdv1p	B
functions	O
later	O
during	O
fission	O
to	O
facilitate	O
Dnm1p	B
-	O
dependent	O
mitochondrial	B
membrane	I
constriction	O
and/or	O
division	O
.	O

PEX11alpha	B
is	O
required	O
for	O
peroxisome	B
proliferation	O
in	O
response	O
to	O
4-phenylbutyrate	O
but	O
is	O
dispensable	O
for	O
peroxisome	B
proliferator	I
-	I
activated	I
receptor	I
alpha	I
-	O
mediated	O
peroxisome	B
proliferation	O
.	O

The	O
PEX11	O
peroxisomal	B
membrane	I
proteins	O
promote	O
peroxisome	B
division	O
in	O
multiple	O
eukaryotes	O
.	O

As	O
part	O
of	O
our	O
effort	O
to	O
understand	O
the	O
molecular	O
and	O
physiological	O
functions	O
of	O
PEX11	O
proteins	O
,	O
we	O
disrupted	O
the	O
mouse	O
PEX11alpha	B
gene	O
.	O

Overexpression	O
of	O
PEX11alpha	B
is	O
sufficient	O
to	O
promote	O
peroxisome	B
division	O
,	O
and	O
a	O
class	O
of	O
chemicals	O
known	O
as	O
peroxisome	B
proliferating	O
agents	O
(	O
PPAs	O
)	O
induce	O
the	O
expression	O
of	O
PEX11alpha	B
and	O
promote	O
peroxisome	B
division	O
.	O

These	O
observations	O
led	O
to	O
the	O
hypothesis	O
that	O
PPAs	O
induce	O
peroxisome	B
abundance	O
by	O
enhancing	O
PEX11alpha	B
expression	O
.	O

The	O
phenotypes	O
of	O
PEX11alpha	B
(	O
-	O
/	O
-	O
)	O
mice	O
indicate	O
that	O
this	O
hypothesis	O
remains	O
valid	O
for	O
a	O
novel	O
class	O
of	O
PPAs	O
that	O
act	O
independently	O
of	O
peroxisome	B
proliferator	I
-	I
activated	I
receptor	I
alpha	I
(	O
PPARalpha	B
)	O
but	O
is	O
not	O
valid	O
for	O
the	O
classical	O
PPAs	O
that	O
act	O
as	O
activators	O
of	O
PPARalpha	B
.	O

Furthermore	O
,	O
we	O
find	O
that	O
PEX11alpha	B
(	O
-	O
/	O
-	O
)	O
mice	O
have	O
normal	O
peroxisome	B
abundance	O
and	O
that	O
cells	O
lacking	O
both	O
PEX11alpha	B
and	O
PEX11beta	B
,	O
a	O
second	O
mammalian	O
PEX11	O
gene	O
,	O
have	O
no	O
greater	O
defect	O
in	O
peroxisome	B
abundance	O
than	O
do	O
cells	O
lacking	O
only	O
PEX11beta	B
.	O

Finally	O
,	O
we	O
report	O
the	O
identification	O
of	O
a	O
third	O
mammalian	O
PEX11	O
gene	O
,	O
PEX11gamma	B
,	O
and	O
show	O
that	O
it	O
too	O
encodes	O
a	O
peroxisomal	B
protein	O
.	O

Functional	O
proteomic	O
analysis	O
of	O
human	O
nucleolus	O
.	O

The	O
notion	O
of	O
a	O
""""	O
plurifunctional	O
""""	O
nucleolus	O
is	O
now	O
well	O
established	O
.	O

However	O
,	O
molecular	O
mechanisms	O
underlying	O
the	O
biological	O
processes	O
occurring	O
within	O
this	O
nuclear	O
domain	O
remain	O
only	O
partially	O
understood	O
.	O

As	O
a	O
first	O
step	O
in	O
elucidating	O
these	O
mechanisms	O
we	O
have	O
carried	O
out	O
a	O
proteomic	O
analysis	O
to	O
draw	O
up	O
a	O
list	O
of	O
proteins	O
present	O
within	O
nucleoli	O
of	O
HeLa	O
cells	O
.	O

This	O
analysis	O
allowed	O
the	O
identification	O
of	O
213	O
different	O
nucleolar	O
proteins	O
.	O

This	O
catalog	O
complements	O
that	O
of	O
the	O
271	O
proteins	O
obtained	O
recently	O
by	O
others	O
,	O
giving	O
a	O
total	O
of	O
approximately	O
350	O
different	O
nucleolar	O
proteins	O
.	O

Functional	O
classification	O
of	O
these	O
proteins	O
allowed	O
outlining	O
several	O
biological	O
processes	O
taking	O
place	O
within	O
nucleoli	O
.	O

Bioinformatic	O
analyses	O
permitted	O
the	O
assignment	O
of	O
hypothetical	O
functions	O
for	O
43	O
proteins	O
for	O
which	O
no	O
functional	O
information	O
is	O
available	O
.	O

Notably	O
,	O
a	O
role	O
in	O
ribosome	O
biogenesis	O
was	O
proposed	O
for	O
31	O
proteins	O
.	O

More	O
generally	O
,	O
this	O
functional	O
classification	O
reinforces	O
the	O
plurifunctional	O
nature	O
of	O
nucleoli	O
and	O
provides	O
convincing	O
evidence	O
that	O
nucleoli	O
may	O
play	O
a	O
central	O
role	O
in	O
the	O
control	O
of	O
gene	O
expression	O
.	O

Finally	O
,	O
this	O
analysis	O
supports	O
the	O
recent	O
demonstration	O
of	O
a	O
coupling	O
of	O
transcription	O
and	O
translation	O
in	O
higher	O
eukaryotes	O
.	O

Genomic	O
structure	O
,	O
gene	O
expression	O
,	O
and	O
promoter	O
analysis	O
of	O
human	O
multidrug	B
resistance	I
-	I
associated	I
protein	I
7	I
.	O

The	O
multidrug	O
resistance	O
-	O
associated	O
protein	O
(	O
MRP	O
)	O
subfamily	O
transporters	O
associated	O
with	O
anticancer	O
drug	O
efflux	O
are	O
attributed	O
to	O
the	O
multidrug	O
-	O
resistance	O
of	O
cancer	O
cells	O
.	O

The	O
genomic	O
organization	O
of	O
human	O
multidrug	B
resistance	I
-	I
associated	I
protein	I
7	I
(	O
MRP7	B
)	O
was	O
identified	O
.	O

The	O
human	O
MRP7	B
gene	O
,	O
consisting	O
of	O
22	O
exons	O
and	O
21	O
introns	O
,	O
greatly	O
differs	O
from	O
other	O
members	O
of	O
the	O
human	O
MRP	O
subfamily	O
.	O

A	O
splicing	O
variant	O
of	O
human	O
MRP7	B
,	O
MRP7A	B
,	O
expressed	O
in	O
most	O
human	O
tissues	O
,	O
was	O
also	O
characterized	O
.	O

The	O
1.93-kb	O
promoter	O
region	O
of	O
MRP7	B
was	O
isolated	O
and	O
shown	O
to	O
support	O
luciferase	O
activity	O
at	O
a	O
level	O
4-	O
to	O
5-fold	O
greater	O
than	O
that	O
of	O
the	O
SV40	O
promoter	O
.	O

Basal	O
MRP7	B
gene	O
expression	O
was	O
regulated	O
by	O
2	O
regions	O
in	O
the	O
5'-flanking	O
region	O
at	O
-1,780	O
-	O
1,287	O
bp	O
,	O
and	O
at	O
-611	O
to	O
-208	O
bp	O
.	O

In	O
Madin	O
-	O
Darby	O
canine	O
kidney	O
(	O
MDCK	O
)	O
cells	O
,	O
MRP7	B
promoter	O
activity	O
was	O
increased	O
by	O
226	O
%	O
by	O
genotoxic	O
2-acetylaminofluorene	O
and	O
347	O
%	O
by	O
the	O
histone	O
deacetylase	O
inhibitor	O
,	O
trichostatin	B
A.	I
The	O
protein	O
was	O
expressed	O
in	O
the	O
membrane	B
fraction	O
of	O
transfected	O
MDCK	O
cells	O
.	O

YMR313c	B
/	O
TGL3	B
encodes	O
a	O
novel	O
triacylglycerol	O
lipase	O
located	O
in	O
lipid	B
particles	I
of	O
Saccharomyces	O
cerevisiae	O
.	O

Previous	O
work	O
from	O
our	O
laboratory	O
(	O
Athenstaedt	O
,	O
K.	O
,	O
Zweytick	O
,	O
D.	O
,	O
Jandrositz	O
,	O
A.	O
,	O
Kohlwein	O
,	O
S.	O
D.	O
,	O
and	O
Daum	O
,	O
G.	O
(	O
1999	O
)	O
J.	O
Bacteriol	O
.	O

181	O
,	O
6441	O
-	O
6448	O
)	O
showed	O
that	O
the	O
gene	O
product	O
of	O
YMR313c	B
(	O
named	O
Tgl3p	B
)	O
is	O
a	O
component	O
of	O
yeast	O
lipid	B
particles	I
,	O
and	O
deletion	O
of	O
this	O
gene	O
led	O
to	O
an	O
increase	O
in	O
the	O
cellular	O
level	O
of	O
triacylglycerols	O
(	O
TAG	O
)	O
.	O

These	O
observations	O
suggested	O
that	O
TGL3	B
may	O
encode	O
a	O
TAG	O
lipase	O
of	O
Saccharomyces	O
cerevisiae	O
.	O

Here	O
we	O
demonstrate	O
by	O
cell	O
fractionation	O
and	O
by	O
microscopic	O
inspection	O
of	O
a	O
strain	O
bearing	O
a	O
Tgl3p	B
-	O
GFP	B
hybrid	O
that	O
this	O
polypeptide	O
is	O
highly	O
enriched	O
in	O
the	O
lipid	B
particle	I
fraction	O
but	O
virtually	O
absent	O
from	O
other	O
organelles	O
.	O

The	O
entire	O
TAG	O
lipase	O
activity	O
of	O
lipid	B
particles	I
is	O
attributed	O
to	O
Tgl3p	B
,	O
because	O
the	O
activity	O
in	O
this	O
organelle	O
is	O
completely	O
absent	O
in	O
a	O
Deltatgl3	B
deletion	O
mutant	O
,	O
whereas	O
it	O
is	O
significantly	O
enhanced	O
in	O
a	O
strain	O
overexpressing	O
Tgl3p	B
.	O

A	O
His6-tagged	B
Tgl3p	B
hybrid	O
purified	O
close	O
to	O
homogeneity	O
from	O
a	O
yeast	O
strain	O
overexpressing	O
this	O
fusion	O
protein	O
exhibited	O
high	O
TAG	O
lipase	O
activity	O
.	O

Most	O
importantly	O
,	O
experiments	O
in	O
vivo	O
using	O
the	O
fatty	O
acid	O
synthesis	O
inhibitor	O
cerulenin	O
demonstrated	O
that	O
deletion	O
of	O
TGL3	B
resulted	O
in	O
a	O
decreased	O
mobilization	O
of	O
TAG	O
from	O
lipid	B
particles	I
.	O

The	O
amino	O
acid	O
sequence	O
deduced	O
from	O
the	O
open	O
reading	O
frame	O
YMR313c	B
contains	O
the	O
consensus	O
sequence	O
motif	O
GXSXG	O
typical	O
for	O
lipolytic	O
enzymes	O
.	O

Otherwise	O
,	O
Tgl3p	B
has	O
no	O
significant	O
sequence	O
homology	O
to	O
other	O
lipases	O
identified	O
so	O
far	O
.	O

In	O
summary	O
,	O
our	O
data	O
identified	O
Tgl3p	B
as	O
a	O
novel	O
yeast	O
TAG	O
lipase	O
at	O
the	O
molecular	O
level	O
and	O
by	O
function	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

Biochemical	O
features	O
of	O
the	O
MHC	B
-	I
related	I
protein	I
1	I
consistent	O
with	O
an	O
immunological	O
function	O
.	O

MHC	B
-	I
related	I
protein	I
(	I
MR	I
)	I
1	I
is	O
an	O
MHC	O
class	O
I	O
-	O
related	O
molecule	O
encoded	O
on	O
chromosome	B
1	O
that	O
is	O
highly	O
conserved	O
among	O
mammals	O
and	O
is	O
more	O
closely	O
related	O
to	O
classical	O
class	O
I	O
molecules	O
than	O
are	O
other	O
nonclassical	O
class	O
I	O
family	O
members	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
for	O
the	O
first	O
time	O
that	O
both	O
mouse	O
and	O
human	O
MR1	B
molecules	O
can	O
associate	O
with	O
the	O
peptide	O
-	O
loading	O
complex	O
and	O
can	O
be	O
detected	O
at	O
low	O
levels	O
at	O
the	O
surface	B
of	O
transfected	O
cells	O
.	O

We	O
also	O
report	O
the	O
production	O
of	O
recombinant	O
human	O
MR1	B
molecules	O
in	O
insect	O
cells	O
using	O
highly	O
supplemented	O
media	O
and	O
provide	O
evidence	O
that	O
the	O
MR1	B
H	O
chain	O
can	O
assume	O
a	O
folded	O
conformation	O
and	O
is	O
stoichiometrically	O
associated	O
with	O
beta	B
(	I
2	I
)	I
-microglobulin	I
,	O
similar	O
to	O
class	O
I	O
molecules	O
.	O

Cumulatively	O
,	O
these	O
findings	O
demonstrate	O
that	O
surface	B
expression	O
of	O
MR1	B
is	O
possible	O
but	O
may	O
be	O
limited	O
by	O
a	O
specific	O
ligand	O
or	O
associated	O
molecule	O
.	O

BRL1	B
and	O
BRL3	B
are	O
novel	O
brassinosteroid	O
receptors	O
that	O
function	O
in	O
vascular	O
differentiation	O
in	O
Arabidopsis	O
.	O

Plant	O
steroid	O
hormones	O
,	O
brassinosteroids	O
(	O
BRs	O
)	O
,	O
are	O
perceived	O
by	O
the	O
plasma	B
membrane	I
-	O
localized	O
leucine	O
-	O
rich	O
-	O
repeat	O
-	O
receptor	O
kinase	O
BRI1	B
.	O

Based	O
on	O
sequence	O
similarity	O
,	O
we	O
have	O
identified	O
three	O
members	O
of	O
the	O
BRI1	B
family	O
,	O
named	O
BRL1	B
,	O
BRL2	B
and	O
BRL3	B
.	O

BRL1	B
and	O
BRL3	B
,	O
but	O
not	O
BRL2	B
,	O
encode	O
functional	O
BR	O
receptors	O
that	O
bind	O
brassinolide	O
,	O
the	O
most	O
active	O
BR	O
,	O
with	O
high	O
affinity	O
.	O

In	O
agreement	O
,	O
only	O
BRL1	B
and	O
BRL3	B
can	O
rescue	O
bri1	B
mutants	O
when	O
expressed	O
under	O
the	O
control	O
of	O
the	O
BRI1	B
promoter	O
.	O

While	O
BRI1	B
is	O
ubiquitously	O
expressed	O
in	O
growing	O
cells	O
,	O
the	O
expression	O
of	O
BRL1	B
and	O
BRL3	B
is	O
restricted	O
to	O
non	O
-	O
overlapping	O
subsets	O
of	O
vascular	O
cells	O
.	O

Loss	O
-	O
of	O
-	O
function	O
of	O
brl1	B
causes	O
abnormal	O
phloem	O
:	O
xylem	O
differentiation	O
ratios	O
and	O
enhances	O
the	O
vascular	O
defects	O
of	O
a	O
weak	O
bri1	B
mutant	O
.	O

bri1	B
brl1	B
brl3	B
triple	O
mutants	O
enhance	O
bri1	B
dwarfism	O
and	O
also	O
exhibit	O
abnormal	O
vascular	O
differentiation	O
.	O

Thus	O
,	O
Arabidopsis	O
contains	O
a	O
small	O
number	O
of	O
BR	O
receptors	O
that	O
have	O
specific	O
functions	O
in	O
cell	O
growth	O
and	O
vascular	O
differentiation	O
.	O

Molecular	O
cloning	O
,	O
expression	O
and	O
immunolocalization	O
of	O
a	O
novel	O
human	O
cementum	O
-	O
derived	O
protein	O
(	O
CP-23	B
)	O
.	O

Cementum	O
is	O
a	O
unique	O
mineralized	O
connective	O
tissue	O
that	O
covers	O
the	O
root	O
surfaces	O
of	O
the	O
teeth	O
.	O

The	O
cementum	O
is	O
critical	O
for	O
appropriate	O
maturation	O
of	O
the	O
periodontium	O
,	O
both	O
during	O
development	O
as	O
well	O
as	O
that	O
associated	O
with	O
regeneration	O
of	O
periodontal	O
tissues	O
,	O
IU	O
;	O
however	O
,	O
one	O
major	O
impediment	O
to	O
understand	O
the	O
molecular	O
mechanisms	O
that	O
regulate	O
periodontal	O
regeneration	O
is	O
the	O
lack	O
of	O
cementum	O
markers	O
.	O

Here	O
we	O
report	O
on	O
the	O
identification	O
and	O
characterization	O
of	O
one	O
such	O
differentially	O
human	O
expressed	O
gene	O
,	O
termed	O
""""	O
cementum	B
protein-23	I
""""	O
(	O
CP-23	B
)	O
that	O
appears	O
to	O
be	O
periodontal	O
ligament	O
and	O
cementum	O
-	O
specific	O
.	O

We	O
screened	O
human	O
cementum	O
tumor	O
-	O
derived	O
cDNA	O
libraries	O
by	O
transient	O
expression	O
in	O
COS-7	O
cells	O
and	O
""""	O
panning	O
""""	O
with	O
a	O
rabbit	O
polyclonal	O
antibody	O
against	O
a	O
cementoblastoma	O
conditioned	O
media	O
-	O
derived	O
protein	O
(	O
CP	O
)	O
.	O

One	O
isolated	O
cDNA	O
,	O
CP-23	B
,	O
was	O
expressed	O
in	O
E.	O
coli	O
and	O
polyclonal	O
antibodies	O
against	O
the	O
recombinant	O
human	O
CP-23	B
were	O
produced	O
.	O

Expression	O
of	O
CP-23	B
protein	O
by	O
cells	O
of	O
the	O
periodontium	O
was	O
examined	O
by	O
Northern	O
blot	O
and	O
in	O
situ	O
hybridization	O
.	O

Expression	O
of	O
CP-23	B
transcripts	O
in	O
human	O
cementoblastoma	O
-	O
derived	O
cells	O
,	O
periodontal	O
ligament	O
cells	O
,	O
human	O
gingival	O
fibroblasts	O
and	O
alveolar	O
bone	O
-	O
derived	O
cells	O
was	O
determined	O
by	O
RT	O
-	O
PCR	O
.	O

Our	O
results	O
show	O
that	O
we	O
have	O
isolated	O
a	O
1374-bp	O
human	O
cDNA	O
containing	O
an	O
open	O
reading	O
frame	O
that	O
encodes	O
a	O
polypeptide	O
with	O
247	O
amino	O
acid	O
residues	O
,	O
with	O
a	O
predicted	O
molecular	O
mass	O
of	O
25.9	O
kDa	O
that	O
represents	O
CP	O
species	O
.	O

The	O
recombinant	O
human	O
CP-23	B
protein	O
cross	O
-	O
reacted	O
with	O
antibodies	O
against	O
CP	O
and	O
type	O
X	O
collagen	O
.	O

Immunoscreening	O
of	O
human	O
periodontal	O
tissues	O
revealed	O
that	O
CP-23	B
gene	O
product	O
is	O
localized	O
to	O
the	O
cementoid	O
matrix	O
of	O
cementum	O
and	O
cementoblasts	O
throughout	O
the	O
entire	O
surface	O
of	O
the	O
root	O
,	O
cell	O
subpopulations	O
of	O
the	O
periodontal	O
ligament	O
as	O
well	O
as	O
cells	O
located	O
paravascularly	O
to	O
the	O
blood	O
vessels	O
into	O
the	O
periodontal	O
ligament	O
.	O

Furthermore	O
,	O
98	O
%	O
of	O
putative	O
cementoblasts	O
and	O
15	O
%	O
of	O
periodontal	O
ligament	O
cells	O
cultured	O
in	O
vitro	O
expressed	O
CP-23	B
gene	O
product	O
.	O

Cementoblastoma	O
cells	O
and	O
periodontal	O
ligament	O
cells	O
contained	O
a	O
5.0	O
kb	O
CP-23	B
mRNA	O
.	O

In	O
situ	O
hybridization	O
showed	O
strong	O
expression	O
of	O
CP-23	B
mRNA	O
on	O
cementoblast	O
,	O
cell	O
subpopulations	O
of	O
the	O
periodontal	O
ligament	O
and	O
cells	O
located	O
around	O
blood	O
vessels	O
into	O
the	O
periodontal	O
ligament	O
.	O

Our	O
results	O
demonstrate	O
that	O
CP-23	B
represents	O
a	O
novel	O
,	O
tissue	O
-	O
specific	O
-	O
gene	O
product	O
being	O
expressed	O
by	O
periodontal	O
ligament	O
subpopulations	O
and	O
cementoblasts	O
.	O

These	O
findings	O
offer	O
the	O
possibility	O
to	O
determine	O
the	O
cellular	O
and	O
molecular	O
events	O
that	O
regulate	O
the	O
cementogenesis	O
process	O
during	O
root	O
development	O
.	O

Furthermore	O
,	O
it	O
might	O
provide	O
new	O
venues	O
for	O
the	O
design	O
of	O
translational	O
studies	O
aimed	O
at	O
achieving	O
predictable	O
new	O
cementogenesis	O
and	O
regeneration	O
of	O
the	O
periodontal	O
tissues	O
.	O

Nuclear	B
localisation	O
of	O
endogenous	O
SUMO-1-modified	B
PDGF	B
-	I
C	I
in	O
human	O
thyroid	O
tissue	O
and	O
cell	O
lines	O
.	O

We	O
investigated	O
post	O
-	O
translational	O
modification	O
and	O
subcellular	O
localisation	O
of	O
endogenous	O
platelet	B
-	I
derived	I
growth	I
factor	I
-	I
C	I
(	O
PDGF	B
-	I
C	I
)	O
in	O
human	O
thyroid	O
papillary	O
carcinomas	O
(	O
PTC	O
)	O
,	O
non	O
-	O
neoplastic	O
thyroid	O
tissues	O
,	O
and	O
a	O
selection	O
of	O
cultured	O
cell	O
lines	O
.	O

PDGF	B
-	I
C	I
expressed	O
nuclear	B
localisation	O
in	O
95	O
%	O
of	O
all	O
tested	O
cell	O
types	O
in	O
culture	O
and	O
in	O
10	O
%	O
of	O
the	O
thyrocytes	O
from	O
both	O
PTC	O
and	O
non	O
-	O
neoplastic	O
tissue	O
.	O

The	O
cell	O
lines	O
expressed	O
two	O
forms	O
of	O
full	O
-	O
length	O
PDGF	B
-	I
C	I
,	O
approximately	O
39	O
and	O
approximately	O
55	O
kDa	O
,	O
in	O
cell	B
membrane	I
and	O
cytosol	B
,	O
while	O
the	O
approximately	O
55	O
kDa	O
form	O
dominated	O
in	O
the	O
nucleus	B
where	O
it	O
was	O
partly	O
chromatin	O
-	O
associated	O
.	O

The	O
approximately	O
55	O
kDa	O
form	O
was	O
post	O
-	O
translationally	O
modified	O
by	O
SUMO-1	B
.	O

The	O
putative	O
PDGF	B
-	I
C	I
SUMOylation	O
site	O
is	O
the	O
surface	O
exposed	O
(	O
314	O
)	O
lysine	O
part	O
of	O
a	O
positively	O
charged	O
loop	O
(	O
(	O
312	O
)	O
RPKTGVRGLHK	O
(	O
322	O
)	O
)	O
with	O
characteristics	O
of	O
a	O
nuclear	B
localisation	O
signal	O
.	O

The	O
tissue	O
thyrocytes	O
expressed	O
a	O
non	O
-	O
SUMOylated	O
approximately	O
43	O
kDa	O
and	O
the	O
55	O
kDa	O
PDGF	B
-	I
C.	I

The	O
SUMO-1	B
modified	O
approximately	O
55	O
kDa	O
PDGF	B
-	I
C	I
expression	O
was	O
low	O
in	O
PTC	O
where	O
the	O
approximately	O
43	O
kDa	O
PDGF	B
-	I
C	I
dominated	O
.	O

This	O
is	O
in	O
contrast	O
to	O
non	O
-	O
neoplastic	O
tissue	O
and	O
cultured	O
cells	O
where	O
the	O
SUMOylated	O
approximately	O
55	O
kDa	O
PDGF	B
-	I
C	I
was	O
strongly	O
expressed	O
.	O

Our	O
data	O
provide	O
novel	O
evidence	O
for	O
nuclear	B
localisation	O
of	O
PDGF	B
-	I
C	I
,	O
post	O
-	O
translational	O
modification	O
by	O
SUMOylation	O
and	O
the	O
expression	O
of	O
a	O
novel	O
form	O
of	O
PDGF	B
-	I
C	I
in	O
human	O
papillary	O
thyroid	O
carcinomas	O
.	O

Shugoshin	B
collaborates	O
with	O
protein	B
phosphatase	I
2A	I
to	O
protect	O
cohesin	O
.	O

Sister	O
chromatid	O
cohesion	O
,	O
mediated	O
by	O
a	O
complex	O
called	O
cohesin	O
,	O
is	O
crucial	O
--	O
particularly	O
at	O
centromeres	B
--	O
for	O
proper	O
chromosome	B
segregation	O
in	O
mitosis	O
and	O
meiosis	O
.	O

In	O
animal	O
mitotic	O
cells	O
,	O
phosphorylation	O
of	O
cohesin	O
promotes	O
its	O
dissociation	O
from	O
chromosomes	B
,	O
but	O
centromeric	B
cohesin	O
is	O
protected	O
by	O
shugoshin	B
until	O
kinetochores	B
are	O
properly	O
captured	O
by	O
the	O
spindle	B
microtubules	O
.	O

However	O
,	O
the	O
mechanism	O
of	O
shugoshin	B
-	O
dependent	O
protection	O
of	O
cohesin	O
is	O
unknown	O
.	O

Here	O
we	O
find	O
a	O
specific	O
subtype	O
of	O
serine	O
/	O
threonine	O
protein	B
phosphatase	I
2A	I
(	O
PP2A	B
)	O
associating	O
with	O
human	O
shugoshin	B
.	O

PP2A	B
colocalizes	O
with	O
shugoshin	B
at	O
centromeres	B
and	O
is	O
required	O
for	O
centromeric	B
protection	O
.	O

Purified	O
shugoshin	B
complex	O
has	O
an	O
ability	O
to	O
reverse	O
the	O
phosphorylation	O
of	O
cohesin	O
in	O
vitro	O
,	O
suggesting	O
that	O
dephosphorylation	O
of	O
cohesin	O
is	O
the	O
mechanism	O
of	O
protection	O
at	O
centromeres	B
.	O

Meiotic	O
shugoshin	B
of	O
fission	O
yeast	O
also	O
associates	O
with	O
PP2A	B
,	O
with	O
both	O
proteins	O
collaboratively	O
protecting	O
Rec8-containing	B
cohesin	O
at	O
centromeres	B
.	O

Thus	O
,	O
we	O
have	O
revealed	O
a	O
conserved	O
mechanism	O
of	O
centromeric	B
protection	O
of	O
eukaryotic	O
chromosomes	B
in	O
mitosis	O
and	O
meiosis	O
.	O

Identification	O
and	O
characterization	O
of	O
a	O
novel	O
zinc	O
finger	O
protein	O
(	O
HZF1	B
)	O
gene	O
and	O
its	O
function	O
in	O
erythroid	O
and	O
megakaryocytic	O
differentiation	O
of	O
K562	O
cells	O
.	O

A	O
novel	O
zinc	O
finger	O
protein	O
(	O
HZF1	B
)	O
gene	O
was	O
identified	O
and	O
characterized	O
by	O
screening	O
a	O
human	O
bone	O
marrow	O
cDNA	O
library	O
,	O
using	O
a	O
new	O
expression	O
sequence	O
tag	O
probe	O
that	O
contains	O
sequences	O
encoding	O
zinc	O
finger	O
motifs	O
.	O

There	O
are	O
at	O
least	O
three	O
transcripts	O
that	O
may	O
result	O
from	O
different	O
splicing	O
of	O
the	O
pre	O
-	O
mRNA	O
,	O
but	O
the	O
differences	O
among	O
them	O
are	O
only	O
involved	O
in	O
5	O
'	O
non	O
-	O
translation	O
region	O
of	O
HZF1	B
mRNA	O
.	O

HZF1	B
gene	O
contains	O
four	O
exons	O
and	O
three	O
introns	O
.	O

The	O
putative	O
protein	O
consists	O
of	O
670	O
amino	O
-	O
acid	O
residues	O
including	O
15	O
typical	O
C2H2	O
and	O
2	O
C2RH	O
zinc	O
finger	O
motifs	O
.	O

This	O
structure	O
characterization	O
of	O
HZF1	B
and	O
the	O
nuclear	B
location	O
of	O
the	O
protein	O
suggest	O
that	O
HZF1	B
may	O
function	O
as	O
a	O
transcription	O
factor	O
.	O

HZF1	B
mRNA	O
expression	O
was	O
detected	O
in	O
ubiquitous	O
tissues	O
and	O
various	O
hematopoietic	O
cell	O
lines	O
.	O

Increased	O
HZF1	B
mRNA	O
expression	O
was	O
observed	O
following	O
erythroid	O
differentiation	O
of	O
K562	O
cells	O
induced	O
by	O
hemin	O
or	O
megakaryocytic	O
differentiation	O
of	O
K562	O
cells	O
induced	O
by	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
.	O

Both	O
of	O
the	O
antisense	O
method	O
and	O
RNA	O
interference	O
assay	O
revealed	O
that	O
repression	O
of	O
the	O
intrinsic	O
expression	O
of	O
HZF1	B
blocked	O
the	O
hemin	O
-	O
induced	O
erythroid	O
differentiation	O
and	O
reduced	O
the	O
PMA	O
-	O
induced	O
megakaryocytic	O
differentiation	O
of	O
K562	O
cells	O
,	O
which	O
suggested	O
that	O
HZF1	B
play	O
important	O
roles	O
in	O
erythroid	O
and	O
megakaryocytic	O
differentiation	O
.	O

Reversible	O
lysine	O
acetylation	O
controls	O
the	O
activity	O
of	O
the	O
mitochondrial	B
enzyme	O
acetyl	B
-	I
CoA	I
synthetase	I
2	I
.	O

We	O
report	O
that	O
human	O
acetyl	B
-	I
CoA	I
synthetase	I
2	I
(	O
AceCS2	B
)	O
is	O
a	O
mitochondrial	B
matrix	I
protein	O
.	O

AceCS2	B
is	O
reversibly	O
acetylated	O
at	O
Lys-642	O
in	O
the	O
active	O
site	O
of	O
the	O
enzyme	O
.	O

The	O
mitochondrial	B
sirtuin	O
SIRT3	B
interacts	O
with	O
AceCS2	B
and	O
deacetylates	O
Lys-642	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Deacetylation	O
of	O
AceCS2	B
by	O
SIRT3	B
activates	O
the	O
acetyl	O
-	O
CoA	O
synthetase	O
activity	O
of	O
AceCS2	B
.	O

This	O
report	O
identifies	O
the	O
first	O
acetylated	O
substrate	O
protein	O
of	O
SIRT3	B
.	O

Our	O
findings	O
show	O
that	O
a	O
mammalian	O
sirtuin	O
directly	O
controls	O
the	O
activity	O
of	O
a	O
metabolic	O
enzyme	O
by	O
means	O
of	O
reversible	O
lysine	O
acetylation	O
.	O

Because	O
the	O
activity	O
of	O
a	O
bacterial	O
ortholog	O
of	O
AceCS2	B
,	O
called	O
ACS	B
,	O
is	O
controlled	O
via	O
deacetylation	O
by	O
a	O
bacterial	O
sirtuin	O
protein	O
,	O
our	O
observation	O
highlights	O
the	O
conservation	O
of	O
a	O
metabolic	O
regulatory	O
pathway	O
from	O
bacteria	O
to	O
humans	O
.	O

Detection	O
of	O
autoantibodies	O
to	O
the	O
BTB	O
-	O
kelch	O
protein	O
KLHL7	B
in	O
cancer	O
sera	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
search	O
for	O
novel	O
targets	O
of	O
autoantibodies	O
in	O
patients	O
with	O
paraneoplastic	O
neurological	O
syndromes	O
(	O
PNS	O
)	O
.	O

PNS	O
are	O
mediated	O
by	O
immune	O
reactions	O
against	O
autoantigen	O
(	O
s	O
)	O
shared	O
by	O
the	O
cancer	O
cells	O
and	O
the	O
nervous	O
system	O
.	O

By	O
serological	O
screening	O
of	O
a	O
rat	O
cerebellum	O
cDNA	O
expression	O
library	O
using	O
anti	O
-	O
Hu	O
-	O
positive	O
sera	O
from	O
three	O
patients	O
with	O
paraneoplastic	O
encephalomyelitis	O
(	O
PEM	O
)	O
,	O
we	O
identified	O
an	O
open	O
reading	O
frame	O
encoding	O
an	O
isoform	O
of	O
the	O
BTB	O
-	O
kelch	O
protein	O
KLHL7	B
.	O

Immunohistochemical	O
studies	O
demonstrated	O
that	O
the	O
KLHL7	B
protein	O
is	O
expressed	O
in	O
the	O
nuclei	B
of	O
neurones	O
,	O
but	O
not	O
in	O
other	O
tissues	O
including	O
various	O
cancers	O
.	O

However	O
,	O
the	O
KLHL7	B
protein	O
was	O
detected	O
in	O
the	O
nuclei	B
of	O
cancer	O
cell	O
lines	O
.	O

Antibodies	O
to	O
KLHL7	B
were	O
detected	O
by	O
an	O
immunoprecipitation	O
assay	O
in	O
sera	O
from	O
12	O
of	O
254	O
(	O
4.7	O
%	O
)	O
patients	O
with	O
various	O
cancers	O
and	O
2	O
of	O
170	O
blood	O
donors	O
(	O
1.2	O
%	O
)	O
.	O

None	O
of	O
50	O
sera	O
from	O
patients	O
with	O
multiple	O
sclerosis	O
were	O
positive	O
for	O
KLHL7	B
antibodies	O
.	O

Sixteen	O
patients	O
with	O
classical	O
PNS	O
and	O
anti	O
-	O
Hu	O
or	O
anti	O
-	O
Yo	O
antibodies	O
were	O
also	O
negative	O
for	O
KLHL7	B
antibodies	O
.	O

Seven	O
cancer	O
patients	O
with	O
KLHL7	B
antibodies	O
had	O
various	O
signs	O
of	O
neurological	O
disease	O
that	O
could	O
be	O
related	O
to	O
cancer	O
,	O
whereas	O
the	O
remaining	O
five	O
seropositive	O
cancer	O
patients	O
had	O
no	O
clinical	O
signs	O
of	O
possible	O
PNS	O
.	O

The	O
present	O
results	O
indicate	O
that	O
KLHL7	B
antibodies	O
are	O
associated	O
with	O
various	O
cancers	O
,	O
and	O
in	O
some	O
patients	O
also	O
with	O
neurological	O
disease	O
.	O

Whether	O
KLHL7	B
antibodies	O
can	O
be	O
used	O
as	O
paraneoplastic	O
markers	O
for	O
PNS	O
remains	O
to	O
be	O
determined	O
.	O

Quantitative	O
phosphoproteomics	O
of	O
early	O
elicitor	O
signaling	O
in	O
Arabidopsis	O
.	O

Perception	O
of	O
general	O
elicitors	O
by	O
plant	O
cells	O
initiates	O
signal	O
transduction	O
cascades	O
that	O
are	O
regulated	O
by	O
protein	O
phosphorylation	O
.	O

The	O
earliest	O
signaling	O
events	O
occur	O
within	O
minutes	O
and	O
include	O
ion	O
fluxes	O
across	O
the	O
plasma	B
membrane	I
,	O
activation	O
of	O
MAPKs	O
,	O
and	O
the	O
formation	O
of	O
reactive	O
oxygen	O
species	O
.	O

The	O
phosphorylation	O
events	O
that	O
regulate	O
these	O
signaling	O
cascades	O
are	O
largely	O
unknown	O
.	O

Here	O
we	O
present	O
a	O
mass	O
spectrometry	O
-	O
based	O
quantitative	O
phosphoproteomics	O
approach	O
that	O
identified	O
differentially	O
phosphorylated	O
sites	O
in	O
signaling	O
and	O
response	O
proteins	O
from	O
Arabidopsis	O
cells	O
treated	O
with	O
either	O
flg22	O
or	O
xylanase	O
.	O

Our	O
approach	O
was	O
sensitive	O
enough	O
to	O
quantitate	O
phosphorylation	O
on	O
low	O
abundance	O
signaling	O
proteins	O
such	O
as	O
calcium	O
-	O
dependent	O
protein	O
kinases	O
and	O
receptor	O
-	O
like	O
kinase	O
family	O
members	O
.	O

With	O
this	O
approach	O
we	O
identified	O
one	O
or	O
more	O
differentially	O
phosphorylated	O
sites	O
in	O
76	O
membrane	B
-	O
associated	O
proteins	O
including	O
a	O
number	O
of	O
defense	O
-	O
related	O
proteins	O
.	O

Our	O
data	O
on	O
phosphorylation	O
indicate	O
a	O
high	O
degree	O
of	O
complexity	O
at	O
the	O
level	O
of	O
post	O
-	O
translational	O
modification	O
as	O
exemplified	O
by	O
the	O
complex	O
modification	O
patterns	O
of	O
respiratory	B
burst	I
oxidase	I
protein	I
D.	I
Furthermore	O
the	O
data	O
also	O
suggest	O
that	O
protein	O
translocation	O
and	O
vesicle	O
traffic	O
are	O
important	O
aspects	O
of	O
early	O
signaling	O
and	O
defense	O
in	O
response	O
to	O
general	O
elicitors	O
.	O

Our	O
study	O
presents	O
the	O
largest	O
quantitative	O
Arabidopsis	O
phosphoproteomics	O
data	O
set	O
to	O
date	O
and	O
provides	O
a	O
new	O
resource	O
that	O
can	O
be	O
used	O
to	O
gain	O
novel	O
insight	O
into	O
plant	O
defense	O
signal	O
transduction	O
and	O
early	O
defense	O
response	O
.	O

An	O
endoplasmic	B
reticulum	I
transmembrane	B
prolyl	I
4-hydroxylase	I
is	O
induced	O
by	O
hypoxia	O
and	O
acts	O
on	O
hypoxia	O
-	O
inducible	O
factor	O
alpha	O
.	O

Prolyl	O
4-hydroxylases	O
(	O
P4Hs	O
)	O
act	O
on	O
collagens	O
(	O
C	O
-	O
P4Hs	O
)	O
and	O
the	O
oxygen	O
-	O
dependent	O
degradation	O
domains	O
(	O
ODDDs	O
)	O
of	O
hypoxia	O
-	O
inducible	O
factor	O
alpha	O
subunits	O
(	O
HIF	O
-	O
P4Hs	O
)	O
leading	O
to	O
degradation	O
of	O
the	O
latter	O
.	O

We	O
report	O
data	O
on	O
a	O
human	O
P4H	O
possessing	O
a	O
transmembrane	B
domain	O
(	O
P4H	B
-	I
TM	I
)	O
.	O

Its	O
gene	O
is	O
also	O
found	O
in	O
zebrafish	O
but	O
not	O
in	O
flies	O
and	O
nematodes	O
.	O

Its	O
sequence	O
more	O
closely	O
resembles	O
those	O
of	O
the	O
C	O
-	O
P4Hs	O
than	O
the	O
HIF	O
-	O
P4Hs	O
,	O
but	O
it	O
lacks	O
the	O
peptide	O
substrate	O
-	O
binding	O
domain	O
of	O
the	O
C	O
-	O
P4Hs	O
.	O

P4H	B
-	I
TM	I
levels	O
in	O
cultured	O
cells	O
are	O
increased	O
by	O
hypoxia	O
,	O
and	O
P4H	B
-	I
TM	I
is	O
N	O
-	O
glycosylated	O
and	O
is	O
located	O
in	O
endoplasmic	B
reticulum	I
membranes	I
with	O
its	O
catalytic	O
site	O
inside	O
the	O
lumen	B
,	O
a	O
location	O
differing	O
from	O
those	O
of	O
the	O
HIF	O
-	O
P4Hs	O
.	O

Despite	O
this	O
,	O
P4H	B
-	I
TM	I
overexpression	O
in	O
cultured	O
neuroblastoma	O
cells	O
reduced	O
HIF	O
-	O
alpha	O
ODDD	O
reporter	O
construct	O
levels	O
,	O
and	O
its	O
small	O
interfering	O
RNA	O
increased	O
HIF-1alpha	B
protein	O
level	O
,	O
in	O
the	O
same	O
way	O
as	O
those	O
of	O
HIF	O
-	O
P4Hs	O
.	O

Furthermore	O
,	O
recombinant	O
P4H	B
-	I
TM	I
hydroxylated	O
the	O
two	O
critical	O
prolines	O
in	O
HIF-1alpha	B
ODDD	O
in	O
vitro	O
,	O
with	O
a	O
preference	O
for	O
the	O
C	O
-	O
terminal	O
proline	O
,	O
whereas	O
it	O
did	O
not	O
hydroxylate	O
any	O
prolines	O
in	O
recombinant	O
type	O
I	O
procollagen	O
chains	O
.	O

A	O
mechanism	O
for	O
asymmetric	O
segregation	O
of	O
age	O
during	O
yeast	O
budding	O
.	O

Ageing	O
and	O
the	O
mortality	O
that	O
ensues	O
are	O
sustainable	O
for	O
the	O
species	O
only	O
if	O
age	O
is	O
reset	O
in	O
newborns	O
.	O

In	O
budding	O
yeast	O
,	O
buds	B
are	O
made	O
young	O
whereas	O
ageing	O
factors	O
,	O
such	O
as	O
carbonylated	O
proteins	O
and	O
DNA	O
circles	O
,	O
remain	O
confined	O
to	O
the	O
ageing	O
mother	O
cell	O
.	O

The	O
mechanisms	O
of	O
this	O
confinement	O
and	O
their	O
relevance	O
are	O
poorly	O
understood	O
.	O

Here	O
we	O
show	O
that	O
a	O
septin	O
-	O
dependent	O
,	O
lateral	O
diffusion	O
barrier	O
forms	O
in	O
the	O
nuclear	B
envelope	I
and	O
limits	O
the	O
translocation	O
of	O
pre	O
-	O
existing	O
nuclear	B
pores	I
into	O
the	O
bud	B
.	O

The	O
retention	O
of	O
DNA	O
circles	O
within	O
the	O
mother	O
cell	O
depends	O
on	O
the	O
presence	O
of	O
the	O
diffusion	O
barrier	O
and	O
on	O
the	O
anchorage	O
of	O
the	O
circles	O
to	O
pores	O
mediated	O
by	O
the	O
nuclear	B
basket	O
.	O

In	O
accordance	O
with	O
the	O
diffusion	O
barrier	O
ensuring	O
the	O
asymmetric	O
segregation	O
of	O
nuclear	B
age	O
-	O
determinants	O
,	O
the	O
barrier	O
mutant	O
bud6Delta	B
fails	O
to	O
properly	O
reset	O
age	O
in	O
buds	B
.	O

Our	O
data	O
involve	O
septin	O
-	O
dependent	O
diffusion	O
barriers	O
in	O
the	O
confinement	O
of	O
ageing	O
factors	O
to	O
one	O
daughter	O
cell	O
during	O
asymmetric	O
cell	O
division	O
.	O

H2A.Bbd	B
:	O
an	O
X	O
-	O
chromosome	B
-	O
encoded	O
histone	O
involved	O
in	O
mammalian	O
spermiogenesis	O
.	O

Despite	O
the	O
identification	O
of	O
H2A.Bbd	B
as	O
a	O
new	O
vertebrate	O
-	O
specific	O
replacement	O
histone	O
variant	O
several	O
years	O
ago	O
,	O
and	O
despite	O
the	O
many	O
in	O
vitro	O
structural	O
characterizations	O
using	O
reconstituted	O
chromatin	O
complexes	O
consisting	O
of	O
this	O
variant	O
,	O
the	O
existence	O
of	O
H2A.Bbd	B
in	O
the	O
cell	O
and	O
its	O
location	O
has	O
remained	O
elusive	O
.	O

Here	O
,	O
we	O
report	O
that	O
the	O
native	O
form	O
of	O
this	O
variant	O
is	O
present	O
in	O
highly	O
advanced	O
spermiogenic	O
fractions	O
of	O
mammalian	O
testis	O
at	O
the	O
time	O
when	O
histones	O
are	O
highly	O
acetylated	O
and	O
being	O
replaced	O
by	O
protamines	O
.	O

It	O
is	O
also	O
present	O
in	O
the	O
nucleosomal	O
chromatin	O
fraction	O
of	O
mature	O
human	O
sperm	O
.	O

The	O
ectopically	O
expressed	O
non	O
-	O
tagged	O
version	O
of	O
the	O
protein	O
is	O
associated	O
with	O
micrococcal	O
nuclease	O
-	O
refractory	O
insoluble	O
fractions	O
of	O
chromatin	O
and	O
in	O
mouse	O
(	O
20T1	O
/	O
2	O
)	O
cell	O
line	O
,	O
H2A.Bbd	B
is	O
enriched	O
at	O
the	O
periphery	O
of	O
chromocenters	B
.	O

The	O
exceedingly	O
rapid	O
evolution	O
of	O
this	O
unique	O
X	O
-	O
chromosome	B
-	O
linked	O
histone	O
variant	O
is	O
shared	O
with	O
other	O
reproductive	O
proteins	O
including	O
those	O
associated	O
with	O
chromatin	O
in	O
the	O
mature	O
sperm	O
(	O
protamines	O
)	O
of	O
many	O
vertebrates	O
.	O

This	O
common	O
rate	O
of	O
evolution	O
provides	O
further	O
support	O
for	O
the	O
functional	O
and	O
structural	O
involvement	O
of	O
this	O
protein	O
in	O
male	O
gametogenesis	O
in	O
mammals	O
.	O

HERC2	B
coordinates	O
ubiquitin	O
-	O
dependent	O
assembly	O
of	O
DNA	O
repair	O
factors	O
on	O
damaged	O
chromosomes	B
.	O

Regulatory	O
ubiquitylation	O
is	O
emerging	O
as	O
an	O
important	O
mechanism	O
to	O
protect	O
genome	O
integrity	O
in	O
cells	O
exposed	O
to	O
DNA	O
damage	O
.	O

However	O
,	O
the	O
spectrum	O
of	O
known	O
ubiquitin	O
regulators	O
of	O
the	O
DNA	O
damage	O
response	O
(	O
DDR	O
)	O
is	O
limited	O
and	O
their	O
functional	O
interplay	O
is	O
poorly	O
understood	O
.	O

Here	O
,	O
we	O
identify	O
HERC2	B
as	O
a	O
factor	O
that	O
regulates	O
ubiquitin	O
-	O
dependent	O
retention	O
of	O
repair	O
proteins	O
on	O
damaged	O
chromosomes	B
.	O

In	O
response	O
to	O
ionising	O
radiation	O
(	O
IR	O
)	O
,	O
HERC2	B
forms	O
a	O
complex	O
with	O
RNF8	B
,	O
a	O
ubiquitin	O
ligase	O
involved	O
in	O
the	O
DDR	O
.	O

The	O
HERC2-RNF8	B
interaction	O
requires	O
IR	O
-	O
inducible	O
phosphorylation	O
of	O
HERC2	B
at	O
Thr	O
4827	O
,	O
which	O
in	O
turn	O
binds	O
to	O
the	O
forkhead	O
-	O
associated	O
(	O
FHA	O
)	O
domain	O
of	O
RNF8	B
.	O

Mechanistically	O
,	O
we	O
provide	O
evidence	O
that	O
HERC2	B
facilitates	O
assembly	O
of	O
the	O
ubiquitin	O
-	O
conjugating	O
enzyme	O
Ubc13	B
with	O
RNF8	B
,	O
thereby	O
promoting	O
DNA	O
damage	O
-	O
induced	O
formation	O
of	O
Lys	O
63-linked	O
ubiquitin	O
chains	O
.	O

We	O
also	O
show	O
that	O
HERC2	B
interacts	O
with	O
,	O
and	O
maintains	O
the	O
levels	O
of	O
,	O
RNF168	B
,	O
another	O
ubiquitin	O
ligase	O
operating	O
downstream	O
of	O
RNF8	B
(	O
Refs	O
7	O
,	O
8)	O
.	O

Consequently	O
,	O
knockdown	O
of	O
HERC2	B
abrogates	O
ubiquitin	O
-	O
dependent	O
retention	O
of	O
repair	O
factors	O
such	O
as	O
53BP1	B
,	O
RAP80	B
and	O
BRCA1	B
.	O

Together	O
with	O
the	O
increased	O
radiosensitivity	O
of	O
HERC2-depleted	B
cells	O
,	O
these	O
results	O
uncover	O
a	O
regulatory	O
layer	O
in	O
the	O
orchestration	O
of	O
protein	O
interactions	O
on	O
damaged	O
chromosomes	B
and	O
they	O
underscore	O
the	O
role	O
of	O
ubiquitin	O
-	O
mediated	O
signalling	O
in	O
genome	O
maintenance	O
.	O

Characterization	O
of	O
a	O
putative	O
3-deoxy	B
-	I
D	I
-	I
manno-2-octulosonic	I
acid	I
(	I
Kdo	I
)	I
transferase	I
gene	O
from	O
Arabidopsis	O
thaliana	O
.	O

The	O
structures	O
of	O
the	O
pectic	O
polysaccharide	O
rhamnogalacturonan	O
II	O
(	O
RG	O
-	O
II	O
)	O
pectin	O
constituent	O
are	O
remarkably	O
evolutionary	O
conserved	O
in	O
all	O
plant	O
species	O
.	O

At	O
least	O
12	O
different	O
glycosyl	O
residues	O
are	O
present	O
in	O
RG	O
-	O
II	O
.	O

Among	O
them	O
is	O
the	O
seldom	O
eight	O
-	O
carbon	O
sugar	O
3-deoxy	O
-	O
d	O
-	O
manno	O
-	O
octulosonic	O
acid	O
(	O
Kdo	O
)	O
whose	O
biosynthetic	O
pathway	O
has	O
been	O
shown	O
to	O
be	O
conserved	O
between	O
plants	O
and	O
Gram	O
-	O
negative	O
bacteria	O
.	O

Kdo	O
is	O
formed	O
in	O
the	O
cytosol	B
by	O
the	O
condensation	O
of	O
phosphoenol	O
pyruvate	O
with	O
d	O
-	O
arabinose-5-P	O
and	O
then	O
activated	O
by	O
coupling	O
to	O
cytidine	O
monophosphate	O
(	O
CMP	O
)	O
prior	O
to	O
its	O
incorporation	O
in	O
the	O
Golgi	B
apparatus	I
by	O
a	O
Kdo	B
transferase	I
(	O
KDTA	B
)	O
into	O
the	O
nascent	O
polysaccharide	O
RG	O
-	O
II	O
.	O

To	O
gain	O
new	O
insight	O
into	O
RG	O
-	O
II	O
biosynthesis	O
and	O
function	O
,	O
we	O
isolated	O
and	O
characterized	O
null	O
mutants	O
for	O
the	O
unique	O
putative	O
KDTA	B
(	O
AtKDTA	B
)	O
encoded	O
in	O
the	O
Arabidopsis	O
genome	O
.	O

We	O
provide	O
evidence	O
that	O
,	O
in	O
contrast	O
to	O
mutants	O
affecting	O
the	O
RG	O
-	O
II	O
biosynthesis	O
,	O
the	O
extinction	O
of	O
the	O
AtKDTA	B
gene	O
expression	O
does	O
not	O
result	O
in	O
any	O
developmental	O
phenotype	O
in	O
the	O
AtkdtA	B
plants	O
.	O

Furthermore	O
,	O
the	O
structure	O
of	O
RG	O
-	O
II	O
from	O
the	O
null	O
mutants	O
was	O
not	O
altered	O
and	O
contained	O
wild	O
-	O
type	O
amount	O
of	O
Rha	O
-	O
alpha	O
(	O
1	O
-	O
5	O
)	O
Kdo	O
side	O
chain	O
.	O

The	O
cellular	O
localization	O
of	O
AtKDTA	B
was	O
investigated	O
by	O
using	O
laser	O
scanning	O
confocal	O
imaging	O
of	O
the	O
protein	O
fused	O
to	O
green	B
fluorescent	I
protein	I
.	O

In	O
agreement	O
with	O
its	O
cellular	O
prediction	O
,	O
the	O
fusion	O
protein	O
was	O
demonstrated	O
to	O
be	O
targeted	O
to	O
the	O
mitochondria	B
.	O

These	O
data	O
,	O
together	O
with	O
data	O
deduced	O
from	O
sequence	O
analyses	O
of	O
higher	O
plant	O
genomes	O
,	O
suggest	O
that	O
AtKDTA	B
encodes	O
a	O
putative	O
KDTA	B
involved	O
in	O
the	O
synthesis	O
of	O
a	O
mitochondrial	B
not	O
yet	O
identified	O
lipid	O
A	O
-	O
like	O
molecule	O
rather	O
than	O
in	O
the	O
synthesis	O
of	O
the	O
cell	B
wall	I
RG	O
-	O
II	O
.	O

Arginine	O
metabolism	O
in	O
Saccharomyces	O
cerevisiae	O
:	O
subcellular	O
localization	O
of	O
the	O
enzymes	O
.	O

Subcellular	O
localization	O
of	O
enzymes	O
of	O
arginine	O
metabolism	O
in	O
Saccharomyces	O
cerevisiae	O
was	O
studied	O
by	O
partial	O
fractionation	O
and	O
stepwise	O
homogenization	O
of	O
spheroplast	O
lysates	O
.	O

These	O
enzymes	O
could	O
clearly	O
be	O
divided	O
into	O
two	O
groups	O
.	O

The	O
first	O
group	O
comprised	O
the	O
five	O
enzymes	O
of	O
the	O
acetylated	O
compound	O
cycle	O
,	O
i.e.	O
,	O
acetylglutamate	B
synthase	I
,	O
acetylglutamate	B
kinase	I
,	O
acetylglutamyl	B
-	I
phosphate	I
reductase	I
,	O
acetylornithine	B
aminotransferase	I
,	O
and	O
acetylornithine	B
-	I
glutamate	I
acetyltransferase	I
.	I

These	O
enzymes	O
were	O
exclusively	O
particulate	O
.	O

Comparison	O
with	O
citrate	B
synthase	I
and	O
cytochrome	B
oxidase	I
,	O
and	O
results	O
from	O
isopycnic	O
gradient	O
analysis	O
,	O
suggested	O
that	O
these	O
enzymes	O
were	O
associated	O
with	O
the	O
mitochondria	B
.	O

By	O
contrast	O
,	O
enzymatic	O
activities	O
going	O
from	O
ornithine	O
to	O
arginine	O
,	O
i.e.	O
,	O
arginine	B
pathway	I
-	I
specific	I
carbamoylphosphate	I
synthetase	I
,	O
ornithine	B
carbamoyltransferase	I
,	O
argininosuccinate	B
synthetase	I
,	O
and	O
argininosuccinate	B
lyase	I
,	O
and	O
the	O
two	O
first	O
catabolic	O
enzymes	O
,	O
arginase	B
and	O
ornithine	B
aminotransferase	I
,	O
were	O
in	O
the	O
""""	O
soluble	O
""""	O
fraction	O
of	O
the	O
cell	O
.	O

Identification	O
and	O
characterization	O
of	O
the	O
missing	O
pyrimidine	O
reductase	O
in	O
the	O
plant	O
riboflavin	O
biosynthesis	O
pathway	O
.	O

Riboflavin	O
(	O
vitamin	O
B₂	O
)	O
is	O
the	O
precursor	O
of	O
the	O
flavin	O
coenzymes	O
flavin	O
mononucleotide	O
and	O
flavin	O
adenine	O
dinucleotide	O
.	O

In	O
Escherichia	O
coli	O
and	O
other	O
bacteria	O
,	O
sequential	O
deamination	O
and	O
reduction	O
steps	O
in	O
riboflavin	O
biosynthesis	O
are	O
catalyzed	O
by	O
RibD	B
,	O
a	O
bifunctional	O
protein	O
with	O
distinct	O
pyrimidine	O
deaminase	O
and	O
reductase	O
domains	O
.	O

Plants	O
have	O
two	O
diverged	O
RibD	B
homologs	O
,	O
PyrD	B
and	O
PyrR	B
;	O
PyrR	B
proteins	O
have	O
an	O
extra	O
carboxyl	O
-	O
terminal	O
domain	O
(	O
COG3236	O
)	O
of	O
unknown	O
function	O
.	O

Arabidopsis	O
(	O
Arabidopsis	O
thaliana	O
)	O
PyrD	B
(	O
encoded	O
by	O
At4g20960	B
)	O
is	O
known	O
to	O
be	O
a	O
monofunctional	O
pyrimidine	O
deaminase	O
,	O
but	O
no	O
pyrimidine	O
reductase	O
has	O
been	O
identified	O
.	O

Bioinformatic	O
analyses	O
indicated	O
that	O
plant	O
PyrR	B
proteins	O
have	O
a	O
catalytically	O
competent	O
reductase	O
domain	O
but	O
lack	O
essential	O
zinc	O
-	O
binding	O
residues	O
in	O
the	O
deaminase	O
domain	O
,	O
and	O
that	O
the	O
Arabidopsis	O
PyrR	B
gene	O
(	O
At3g47390	B
)	O
is	O
coexpressed	O
with	O
riboflavin	O
synthesis	O
genes	O
.	O

These	O
observations	O
imply	O
that	O
PyrR	B
is	O
a	O
pyrimidine	O
reductase	O
without	O
deaminase	O
activity	O
.	O

Consistent	O
with	O
this	O
inference	O
,	O
Arabidopsis	O
or	O
maize	O
(	O
Zea	O
mays	O
)	O
PyrR	B
(	O
At3g47390	B
or	O
GRMZM2G090068	B
)	O
restored	O
riboflavin	O
prototrophy	O
to	O
an	O
E.	O
coli	O
ribD	B
deletant	O
strain	O
when	O
coexpressed	O
with	O
the	O
corresponding	O
PyrD	B
protein	O
(	O
At4g20960	B
or	O
GRMZM2G320099	B
)	O
but	O
not	O
when	O
expressed	O
alone	O
;	O
the	O
COG3236	O
domain	O
was	O
unnecessary	O
for	O
complementing	O
activity	O
.	O

Furthermore	O
,	O
recombinant	O
maize	O
PyrR	B
mediated	O
NAD	O
(	O
P	O
)	O
H	O
-	O
dependent	O
pyrimidine	O
reduction	O
in	O
vitro	O
.	O

Import	O
assays	O
with	O
pea	O
(	O
Pisum	O
sativum	O
)	O
chloroplasts	B
showed	O
that	O
PyrR	B
and	O
PyrD	B
are	O
taken	O
up	O
and	O
proteolytically	O
processed	O
.	O

Ablation	O
of	O
the	O
maize	O
PyrR	B
gene	O
caused	O
early	O
seed	O
lethality	O
.	O

These	O
data	O
argue	O
that	O
PyrR	B
is	O
the	O
missing	O
plant	O
pyrimidine	O
reductase	O
,	O
that	O
it	O
is	O
plastid	B
localized	O
,	O
and	O
that	O
it	O
is	O
essential	O
.	O

The	O
role	O
of	O
the	O
COG3236	O
domain	O
remains	O
mysterious	O
;	O
no	O
evidence	O
was	O
obtained	O
for	O
the	O
possibility	O
that	O
it	O
catalyzes	O
the	O
dephosphorylation	O
that	O
follows	O
pyrimidine	O
reduction	O
.	O

Heptahelical	O
protein	O
PQLC2	B
is	O
a	O
lysosomal	B
cationic	O
amino	O
acid	O
exporter	O
underlying	O
the	O
action	O
of	O
cysteamine	O
in	O
cystinosis	O
therapy	O
.	O

Cystinosin	O
,	O
the	O
lysosomal	B
cystine	O
exporter	O
defective	O
in	O
cystinosis	O
,	O
is	O
the	O
founding	O
member	O
of	O
a	O
family	O
of	O
heptahelical	O
membrane	B
proteins	O
related	O
to	O
bacteriorhodopsin	B
and	O
characterized	O
by	O
a	O
duplicated	O
motif	O
termed	O
the	O
PQ	O
loop	O
.	O

PQ	O
-	O
loop	O
proteins	O
are	O
more	O
frequent	O
in	O
eukaryotes	O
than	O
in	O
prokaryotes	O
;	O
except	O
for	O
cystinosin	O
,	O
their	O
molecular	O
function	O
remains	O
elusive	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
that	O
three	O
yeast	O
PQ	O
-	O
loop	O
proteins	O
of	O
unknown	O
function	O
,	O
Ypq1	B
,	O
Ypq2	B
,	O
and	O
Ypq3	B
,	O
localize	O
to	O
the	O
vacuolar	B
membrane	I
and	O
are	O
involved	O
in	O
homeostasis	O
of	O
cationic	O
amino	O
acids	O
(	O
CAAs	O
)	O
.	O

We	O
also	O
show	O
that	O
PQLC2	B
,	O
a	O
mammalian	O
PQ	O
-	O
loop	O
protein	O
closely	O
related	O
to	O
yeast	O
Ypq	O
proteins	O
,	O
localizes	O
to	O
lysosomes	B
and	O
catalyzes	O
a	O
robust	O
,	O
electrogenic	O
transport	O
that	O
is	O
selective	O
for	O
CAAs	O
and	O
strongly	O
activated	O
at	O
low	O
extracytosolic	O
pH.	O
Heterologous	O
expression	O
of	O
PQLC2	B
at	O
the	O
yeast	O
vacuole	B
rescues	O
the	O
resistance	O
phenotype	O
of	O
an	O
ypq2	B
mutant	O
to	O
canavanine	O
,	O
a	O
toxic	O
analog	O
of	O
arginine	O
efficiently	O
transported	O
by	O
PQLC2	B
.	O

Finally	O
,	O
PQLC2	B
transports	O
a	O
lysine	O
-	O
like	O
mixed	O
disulfide	O
that	O
serves	O
as	O
a	O
chemical	O
intermediate	O
in	O
cysteamine	O
therapy	O
of	O
cystinosis	O
,	O
and	O
PQLC2	B
gene	O
silencing	O
trapped	O
this	O
intermediate	O
in	O
cystinotic	O
cells	O
.	O

We	O
conclude	O
that	O
PQLC2	B
and	O
Ypq1	B
-	I
3	I
proteins	O
are	O
lysosomal	B
/	O
vacuolar	B
exporters	O
of	O
CAAs	O
and	O
suggest	O
that	O
small	O
-	O
molecule	O
transport	O
is	O
a	O
conserved	O
feature	O
of	O
the	O
PQ	O
-	O
loop	O
protein	O
family	O
,	O
in	O
agreement	O
with	O
its	O
distant	O
similarity	O
to	O
SWEET	O
sugar	O
transporters	O
and	O
to	O
the	O
mitochondrial	B
pyruvate	O
carrier	O
.	O

The	O
elucidation	O
of	O
PQLC2	B
function	O
may	O
help	O
improve	O
cysteamine	O
therapy	O
.	O

It	O
may	O
also	O
clarify	O
the	O
origin	O
of	O
CAA	O
abnormalities	O
in	O
Batten	O
disease	O
.	O

GOLPH3L	B
antagonizes	O
GOLPH3	B
to	O
determine	O
Golgi	B
morphology	O
.	O

GOLPH3	B
is	O
a	O
phosphatidylinositol-4-phosphate	O
(	O
PI4P	O
)	O
effector	O
that	O
plays	O
an	O
important	O
role	O
in	O
maintaining	O
Golgi	B
architecture	O
and	O
anterograde	O
trafficking	O
.	O

GOLPH3	B
does	O
so	O
through	O
its	O
ability	O
to	O
link	O
trans	O
-	O
Golgi	B
membranes	I
to	O
F	O
-	O
actin	O
via	O
its	O
interaction	O
with	O
myosin	B
18A	I
(	O
MYO18A	B
)	O
.	O

GOLPH3	B
also	O
is	O
known	O
to	O
be	O
an	O
oncogene	O
commonly	O
amplified	O
in	O
human	O
cancers	O
.	O

GOLPH3L	B
is	O
a	O
GOLPH3	B
paralogue	O
found	O
in	O
all	O
vertebrate	O
genomes	O
,	O
although	O
previously	O
it	O
was	O
largely	O
uncharacterized	O
.	O

Here	O
we	O
demonstrate	O
that	O
although	O
GOLPH3	B
is	O
ubiquitously	O
expressed	O
in	O
mammalian	O
cells	O
,	O
GOLPH3L	B
is	O
present	O
in	O
only	O
a	O
subset	O
of	O
tissues	O
and	O
cell	O
types	O
,	O
particularly	O
secretory	O
tissues	O
.	O

We	O
show	O
that	O
,	O
like	O
GOLPH3	B
,	O
GOLPH3L	B
binds	O
to	O
PI4P	O
,	O
localizes	O
to	O
the	O
Golgi	B
as	O
a	O
consequence	O
of	O
its	O
PI4P	O
binding	O
,	O
and	O
is	O
required	O
for	O
efficient	O
anterograde	O
trafficking	O
.	O

Surprisingly	O
,	O
however	O
,	O
we	O
find	O
that	O
perturbations	O
of	O
GOLPH3L	B
expression	O
produce	O
effects	O
on	O
Golgi	B
morphology	O
that	O
are	O
opposite	O
to	O
those	O
of	O
GOLPH3	B
and	O
MYO18A	B
.	O

GOLPH3L	B
differs	O
critically	O
from	O
GOLPH3	B
in	O
that	O
it	O
is	O
largely	O
unable	O
to	O
bind	O
to	O
MYO18A	B
.	O

Our	O
data	O
demonstrate	O
that	O
despite	O
their	O
similarities	O
,	O
unexpectedly	O
,	O
GOLPH3L	B
antagonizes	O
GOLPH3	B
/	O
MYO18A	B
at	O
the	O
Golgi	B
.	O

Molecular	O
cloning	O
of	O
a	O
novel	O
human	O
cDNA	O
encoding	O
a	O
zinc	O
finger	O
protein	O
that	O
binds	O
to	O
the	O
interleukin-3	B
promoter	O
.	O

The	O
CT	O
/	O
GC	O
-	O
rich	O
region	O
(	O
-76	O
to	O
-47	O
)	O
is	O
one	O
transcriptional	O
regulatory	O
region	O
of	O
the	O
interleukin-3	B
(	O
IL-3	B
)	O
gene	O
which	O
confers	O
basic	O
transcriptional	O
activity	O
and	O
responds	O
to	O
trans	O
-	O
activation	O
by	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
I	O
-	O
encoded	O
Tax	O
.	O

We	O
isolated	O
three	O
types	O
of	O
cDNAs	O
encoding	O
Cys2	O
/	O
His2-type	O
zinc	O
finger	O
proteins	O
that	O
bind	O
to	O
this	O
region	O
.	O

Two	O
were	O
identical	O
to	O
known	O
transcription	O
factors	O
,	O
EGR1	B
and	O
EGR2	B
,	O
and	O
the	O
other	O
clone	O
,	O
named	O
DB1	B
,	O
encoded	O
a	O
novel	O
protein	O
of	O
516	O
amino	O
acids	O
with	O
six	O
zinc	O
finger	O
motifs	O
.	O

DB1	B
mRNA	O
was	O
present	O
in	O
human	O
tissues	O
,	O
ubiquitously	O
.	O

Two	O
constitutive	O
transcripts	O
of	O
4.0	O
and	O
4.8	O
kb	O
in	O
length	O
were	O
present	O
in	O
Jurkat	O
cells	O
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
,	O
with	O
specific	O
antibodies	O
,	O
showed	O
that	O
DB1	B
constitutively	O
binds	O
to	O
this	O
region	O
whereas	O
EGR1	B
binds	O
in	O
a	O
T	O
-	O
cell	O
activation	O
-	O
dependent	O
manner	O
.	O

Overexpression	O
of	O
DB1	B
in	O
Jurkat	O
cells	O
had	O
no	O
detectable	O
effect	O
on	O
the	O
transcription	O
activity	O
of	O
the	O
IL-3	B
promoter	O
,	O
in	O
a	O
transient	O
-	O
transfection	O
assay	O
.	O

EGR1	B
and	O
EGR2	B
increased	O
IL-3	B
promoter	O
activity	O
when	O
the	O
transfected	O
cells	O
were	O
stimulated	O
with	O
phorbol-12-myristate-13-acetate	O
and	O
A23187	O
.	O

When	O
DB1	B
was	O
cotransfected	O
with	O
a	O
Tax	O
expression	O
vector	O
,	O
transcription	O
activity	O
of	O
the	O
IL-3	B
promoter	O
induced	O
by	O
Tax	O
was	O
significantly	O
increased	O
,	O
while	O
EGR1	B
and	O
EGR2	B
were	O
without	O
effect	O
.	O

These	O
results	O
suggest	O
that	O
EGR1	B
has	O
a	O
role	O
in	O
inducible	O
transcription	O
of	O
the	O
IL-3	B
gene	O
,	O
while	O
DB1	B
sustains	O
basal	O
transcriptional	O
activity	O
and	O
also	O
cooperates	O
with	O
Tax	O
to	O
activate	O
the	O
IL-3	B
promoter	O
.	O

Sequence	O
analysis	O
of	O
203	O
kilobases	O
from	O
Saccharomyces	O
cerevisiae	O
chromosome	B
VII	O
.	O

The	O
nucleotide	O
sequences	O
of	O
five	O
major	O
regions	O
from	O
chromosome	B
VII	O
of	O
Saccharomyces	O
cerevisiae	O
have	O
been	O
determined	O
and	O
analysed	O
.	O

These	O
regions	O
represent	O
203	O
kilobases	O
corresponding	O
to	O
approximately	O
one	O
-	O
fifth	O
of	O
the	O
complete	O
yeast	O
chromosome	B
VII	O
.	O

Two	O
fragments	O
originate	O
from	O
the	O
left	O
arm	O
of	O
this	O
chromosome	B
.	O

The	O
first	O
one	O
of	O
about	O
15.8	O
kb	O
starts	O
approximately	O
75	O
kb	O
from	O
the	O
left	O
telomere	B
and	O
is	O
bordered	O
by	O
the	O
SK18	O
chromosomal	B
marker	O
.	O

The	O
second	O
fragment	O
covers	O
the	O
72.6	O
kb	O
region	O
between	O
the	O
chromosomal	B
markers	O
CYH2	B
and	O
ALG2	B
.	O

On	O
the	O
right	O
chromosomal	B
arm	O
three	O
regions	O
,	O
a	O
70.6	O
kb	O
region	O
between	O
the	O
MSB2	B
and	O
the	O
KSS1	B
chromosomal	B
markers	O
and	O
two	O
smaller	O
regions	O
dominated	O
by	O
the	O
KRE11	B
marker	O
and	O
another	O
one	O
in	O
the	O
vicinity	O
of	O
the	O
SER2	B
marker	O
were	O
sequenced	O
.	O

We	O
found	O
a	O
total	O
of	O
114	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
,	O
13	O
of	O
which	O
were	O
completely	O
overlapping	O
with	O
larger	O
ORFs	O
running	O
in	O
the	O
opposite	O
direction	O
.	O

A	O
total	O
of	O
44	O
yeast	O
genes	O
,	O
the	O
physiological	O
functions	O
of	O
which	O
are	O
known	O
,	O
could	O
be	O
precisely	O
mapped	O
on	O
this	O
chromosome	B
.	O

Of	O
the	O
remaining	O
57	O
ORFs	O
,	O
26	O
shared	O
sequence	O
homologies	O
with	O
known	O
genes	O
,	O
among	O
which	O
were	O
13	O
other	O
S.	O
cerevisiae	O
genes	O
and	O
five	O
genes	O
from	O
other	O
organisms	O
.	O

No	O
homology	O
with	O
any	O
sequence	O
in	O
the	O
databases	O
could	O
be	O
found	O
for	O
31	O
ORFs	O
.	O

Furthermore	O
,	O
five	O
Ty	O
elements	O
were	O
found	O
,	O
one	O
of	O
which	O
may	O
not	O
be	O
functional	O
due	O
to	O
a	O
frame	O
shift	O
in	O
its	O
Ty1B	B
amino	O
acid	O
sequence	O
.	O

The	O
five	O
chromosomal	B
regions	O
harboured	O
five	O
potential	O
ARS	O
elements	O
and	O
one	O
sigma	O
element	O
together	O
with	O
eight	O
tRNA	O
genes	O
and	O
two	O
snRNAs	O
,	O
one	O
of	O
which	O
is	O
encoded	O
by	O
an	O
intron	O
of	O
a	O
protein	O
-	O
coding	O
gene	O
.	O

A	O
single	O
precursor	O
protein	O
for	O
ferrochelatase	B
-	I
I	I
from	O
Arabidopsis	O
is	O
imported	O
in	O
vitro	O
into	O
both	O
chloroplasts	B
and	O
mitochondria	B
.	O

Ferrochelatase	B
is	O
the	O
last	O
enzyme	O
of	O
heme	O
biosynthesis	O
and	O
in	O
higher	O
plants	O
is	O
found	O
in	O
both	O
chloroplasts	B
and	O
mitochondria	B
.	O

We	O
have	O
isolated	O
cDNAs	O
for	O
two	O
isoforms	O
of	O
ferrochelatase	B
from	O
Arabidopsis	O
thaliana	O
,	O
both	O
of	O
which	O
are	O
imported	O
into	O
isolated	O
chloroplasts	B
.	O

In	O
this	O
paper	O
we	O
show	O
that	O
ferrochelatase	B
-	I
I	I
is	O
also	O
imported	O
into	O
isolated	O
pea	O
mitochondria	B
with	O
approximately	O
the	O
same	O
efficiency	O
as	O
into	O
chloroplasts	B
.	O

Processing	O
of	O
the	O
precursor	O
was	O
observed	O
with	O
both	O
chloroplast	B
stroma	I
and	O
mitochondrial	B
matrix	I
extracts	O
.	O

This	O
was	O
inhibited	O
by	O
EDTA	B
,	O
indicating	O
it	O
was	O
due	O
to	O
the	O
specific	O
processing	O
proteases	O
.	O

The	O
specificity	O
of	O
import	O
was	O
verified	O
by	O
the	O
fact	O
that	O
the	O
mitochondrial	B
preparation	O
did	O
not	O
import	O
the	O
precursor	O
of	O
the	O
light	B
-	I
harvesting	I
chlorophyll	I
a	I
/	I
b	I
protein	I
precursor	O
or	O
the	O
precursor	O
of	O
porphobilinogen	B
deaminase	I
,	O
an	O
earlier	O
enzyme	O
of	O
tetrapyrrole	O
biosynthesis	O
,	O
both	O
of	O
which	O
are	O
exclusively	O
chloroplast	B
-	O
located	O
.	O

Furthermore	O
,	O
import	O
of	O
ferrochelatase	B
-	I
I	I
precursor	O
into	O
mitochondria	B
was	O
inhibited	O
by	O
valinomycin	O
,	O
but	O
this	O
had	O
no	O
effect	O
on	O
its	O
import	O
into	O
chloroplasts	B
.	O

Thus	O
a	O
single	O
precursor	O
molecule	O
is	O
recognized	O
by	O
the	O
import	O
machinery	O
of	O
the	O
two	O
organelles	O
.	O

The	O
implications	O
for	O
the	O
targeting	O
of	O
ferrochelatase	B
in	O
a	O
possible	O
protective	O
role	O
against	O
photooxidative	O
stress	O
are	O
discussed	O
.	O

Screening	O
for	O
glycosylphosphatidylinositol	O
(	O
GPI	O
)	O
-dependent	O
cell	B
wall	I
proteins	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

Open	O
reading	O
frames	O
in	O
the	O
genome	O
of	O
Saccharomyces	O
cerevisiae	O
were	O
screened	O
for	O
potential	O
glycosylphosphatidylinositol	O
(	O
GPI	O
)	O
-attached	O
proteins	O
.	O

The	O
identification	O
of	O
putative	O
GPI	O
-	O
attached	O
proteins	O
was	O
based	O
on	O
three	O
criteria	O
:	O
the	O
presence	O
of	O
a	O
GPI	O
-	O
attachment	O
signal	O
sequence	O
,	O
a	O
signal	O
sequence	O
for	O
secretion	B
and	O
a	O
serine-	O
or	O
threonine	O
-	O
rich	O
sequence	O
.	O

In	O
all	O
,	O
53	O
ORFs	O
met	O
these	O
three	O
criteria	O
and	O
38	O
were	O
further	O
analyzed	O
as	O
follows	O
.	O

The	O
sequence	O
encoding	O
the	O
40	O
C	O
-	O
terminal	O
amino	O
acids	O
of	O
each	O
was	O
fused	O
with	O
the	O
structural	O
gene	O
for	O
a	O
reporter	O
protein	O
consisting	O
of	O
a	O
secretion	B
signal	O
,	O
alpha	B
-	I
galactosidase	I
and	O
a	O
hemagglutinin	B
(	O
HA	B
)	O
epitope	O
,	O
and	O
examined	O
for	O
the	O
ability	O
to	O
become	O
incorporated	O
into	O
the	O
cell	B
wall	I
.	O

On	O
this	O
basis	O
,	O
14	O
of	O
fusion	O
proteins	O
were	O
classified	O
as	O
GPI	O
-	O
dependent	O
cell	B
wall	I
proteins	O
because	O
cells	O
expressing	O
these	O
fusion	O
proteins	O
:	O
(	O
i	O
)	O
had	O
high	O
levels	O
of	O
alpha	B
-	I
galactosidase	I
activity	O
on	O
their	O
surface	B
;	O
(	O
ii	O
)	O
released	O
significant	O
amounts	O
of	O
the	O
fusion	O
proteins	O
from	O
the	O
membrane	B
on	O
treatment	O
with	O
phosphatidylinositol	B
-	I
specific	I
phospholipase	I
C	I
(	O
PI	B
-	I
PLC	I
)	O
;	O
and	O
(	O
iii	O
)	O
released	O
fusion	O
proteins	O
from	O
the	O
cell	B
wall	I
following	O
treatment	O
with	O
laminarinase	B
.	O

Of	O
the	O
14	O
identified	O
putative	O
GPI	O
-	O
dependent	O
cell	B
wall	I
proteins	O
,	O
12	O
had	O
novel	O
ORFs	O
adjacent	O
to	O
their	O
GPI	O
-	O
attachment	O
signal	O
sequence	O
.	O

Amino	O
acid	O
sequence	O
alignment	O
of	O
the	O
C	O
-	O
terminal	O
sequences	O
of	O
the	O
12	O
ORFs	O
,	O
together	O
with	O
those	O
of	O
known	O
cell	B
wall	I
proteins	O
,	O
reveals	O
some	O
sequence	O
similarities	O
among	O
them	O
.	O

